Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Placebo treatment can significantly influence subjective symptoms. However, it is widely believed that response to placebo requires concealment or deception. We tested whether open-label placebo (non-deceptive and non-concealed administration) is superior to a no-treatment control with matched patient-provider interactions in the treatment of irritable bowel syndrome (IBS). METHODS: Two-group, randomized, controlled three week trial (August 2009-April 2010) conducted at a single academic center, involving 80 primarily female (70%) patients, mean age 47 ± 18 with IBS diagnosed by Rome III criteria and with a score ≥ 150 on the IBS Symptom Severity Scale (IBS-SSS). Patients were randomized to either open-label placebo pills presented as "placebo pills made of an inert substance, like sugar pills, that have been shown in clinical studies to produce significant improvement in IBS symptoms through mind-body self-healing processes" or no-treatment controls with the same quality of interaction with providers. The primary outcome was IBS Global Improvement Scale (IBS-GIS). Secondary measures were IBS Symptom Severity Scale (IBS-SSS), IBS Adequate Relief (IBS-AR) and IBS Quality of Life (IBS-QoL). FINDINGS: Open-label placebo produced significantly higher mean (±SD) global improvement scores (IBS-GIS) at both 11-day midpoint (5.2 ± 1.0 vs. 4.0 ± 1.1, p<.001) and at 21-day endpoint (5.0 ± 1.5 vs. 3.9 ± 1.3, p = .002). Significant results were also observed at both time points for reduced symptom severity (IBS-SSS, p = .008 and p = .03) and adequate relief (IBS-AR, p = .02 and p = .03); and a trend favoring open-label placebo was observed for quality of life (IBS-QoL) at the 21-day endpoint (p = .08). CONCLUSION: Placebos administered without deception may be an effective treatment for IBS. Further research is warranted in IBS, and perhaps other conditions, to elucidate whether physicians can benefit patients using placebos consistent with informed consent. TRIAL REGISTRATION: ClinicalTrials.gov NCT01010191.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The number-needed-to-treat was 11 which should be compared with 4 for ‘placebo without deception,259 7 for alosetron,260 8 for linaclotide261 and 14 for tegaserod.262”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [259]
The cited source says what the claim attributes to it.
In the citing paper
“Several trials of psychological treatments for IBS have failed to show differential effects on symptoms when using attention control conditions [32,62-64], and a recent study showed that IBS patients even respond to open-label placebo [65].”
The cited source says what the claim attributes to it.
In the citing paper
“Kaptchuk and colleagues showed that an open label inactive placebo pill produced better outcomes in IBS patients compared to no treatment13.”
From Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial (2014) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Discovery of Grounded Theory; Strategies for Qualitative Research
Glaser, B. G., Strauss, A. L., & Strutzel, E. (1968) · Nursing Research · doi:10.1097/00006199-196807000-00014 · Cited by 39,449
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Collecting and Interpreting Qualitative Materials
Denzin, N. K., & Lincoln, Y. S. (2012) · Cited by 6,094
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · cited 1×
“Participants were adults ($18 years old) meeting the Rome III criteria for IBS [17] with a score of $150 on the IBS Symptom Severity Scale (IBS-SSS).”
MethodFRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708 · cited 3×
“[18] The open-label group improved by 92 points on this measure; in addition, the improvement shown by the openlabel placebo group exceeded that shown by the no-treatment group by 46 points.”
MethodInfluentialIs the Placebo Powerless?: An Analysis of Clinical Trials Comparing Placebo with No Treatment
Hróbjartsson, A., & Gøtzsche, P. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105243442106 · Cited by 1,503
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384 · cited 1×
“[7,8] It is a chronic functional gastrointestinal disorder characterized by abdominal pain and discomfort associated with altered bowel habits.”
BackgroundBiological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Self-citation
Research works printed but not linked: 1
- Vanner SJ Depew WT Paterson WG 2004 Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome and functional dyspepsia. Gut 53 666 72 · DOI · Paper page
Cited by
Items 701–800 of 897
To feel what others feel: two episodes from 18th century medicine
Justman, S. (2011) · Medical Humanities · doi:10.1136/jmh.2011.007203 · Cited by 1
“In a recent study of patients with irritable bowel syndrome, some participants were prescribed an inert medication openly described as ‘placebo pills, something like sugar pills’, but also said to have been ‘shown in rigorous clinical testing to produce significant mind-body self-healing processes’.(12) Invited in thi…”
BackgroundGreen, M. J. (2011) · Medical Humanities · doi:10.1136/jmh.2010.006619 · Cited by 1
“In a recent study of patients with irritable bowel syndrome, some participants were prescribed an inert medication openly described as ‘placebo pills, something like sugar pills’, but also said to have been ‘shown in rigorous clinical testing to produce significant mind-body self-healing processes’.(12) Invited in thi…”
BackgroundHolmes, R. S., Couzens, K., Tsui, V., Hards, L., Wiens, K., & Fenton, T. R. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533613503554 · Cited by 1
van Valkenhoef, G. H. M. (2012) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Reply: Understanding Placebo Science: A Word about Deception
Campbell, N. K. J., & Raz, A. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601113 · Cited by 1
Raza, K. (2016) · e-space (Manchester Metropolitan University) · Cited by 2
Prévost, M., Zuckerman, A., & Gold, I. (2011) · Cited by 1
Neuroética y neuroeducación: repensando la relación entre las neurociencias y las ciencias sociales
(2018) · Recerca Revista de pensament i anàlisi · doi:10.6035/recerca.2018.22 · Cited by 1
Functional motor disorders: mechanism, prognosis and treatment
Gelauff, J. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.136733110 · Cited by 2
Schaefer, M., Kühnel, A., & Enge, S. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000518803 · Cited by 1
Physician Responsibility to Discuss Palliative Unproven Therapies With Out-of-Option Patients
Kawam, O., Tilburt, J. C., & Master, Z. (2021) · The American Journal of Bioethics · doi:10.1080/15265161.2021.1991038 · Cited by 1
“If an openlabel placebo treatment for Irritable Bowel Syndrome can improve patient well-being compared to no treatment, then it is a therapeutic win (Kaptchuk et al. 2010).”
BackgroundColloca, L., Horin, A. P., & Finniss, D. G. (2016) · Wiley eBooks · doi:10.1002/9781118455968.ch9 · Cited by 3
Quantum Theory of Soul Sickness and Soul HealingPreprint
Sha, Z., & Xiu, R. (2024) · Qeios · doi:10.32388/q6otai · Cited by 1
Fendel, J. C., Tiersch, C., Sölder, P., Gaab, J., & Schmidt, S. (2024) · Research Square · doi:10.21203/rs.3.rs-5216072/v1 · Cited by 1
Confirmation Bias Exists in the Face of False InformationPreprint
Razi, H., Sambrook, T. D., & Garrett, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.07.723487 · Cited by 1
Neurobiologie der Plazebowirkung
Müller, M. J. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_52
Ayala, L. M. V. (2014) · Buleria (Universidad de León) · doi:10.18002/10612/3506 · Cited by 2
Psychiatric Applications of Placebos
손인기, & 김임렬 (2014) · 대한정신약물학회지 · Cited by 1
On the ethical use of placebos
Rawlins, R. (2015) · Focus on Alternative and Complementary Therapies · doi:10.1111/fct.12169
Réponse placebo : l’alliance thérapeutique au risque des attentes et des expériences
Cedraschi, C., Piguet, V., & Allaz, A. (2014) · Douleur et Analgésie · doi:10.1007/s11724-014-0402-z
Ritual and Ceremony in Intraoperative Magnetic Resonance Imaging-Assisted Brain Surgery
Gellert, V. (2012) · EXPLORE · doi:10.1016/j.explore.2012.06.004
Homöopathische Arznei, homöopathische Anamnese, Empathie oder gar kein Effekt?
Lüdtke, R. (2011) · Forschende Komplementärmedizin / Research in Complementary Medicine · doi:10.1159/000328064
Placebo composition as tabula rasa in clinical trials
Apte, S. (2016) · International Journal of Pharmaceutical Excipients · doi:10.66617/001c.1116
Percutaneous Suprapubic Tube After Robotic Assisted Radical Prostatectomy: True or Placebo Benefit?
Abdollah, F., & Menon, M. (2014) · European Urology · doi:10.1016/j.eururo.2014.02.050
“For example, in an RCT, Kaptchuk et al. [4] examined the impact of observation, placebo (limited placebo), or placebo plus patient-practitioner relationship (augmented placebo) on irritable bowel syndrome (IBS) symptoms.”
BackgroundInfluentialTwo weeks of rifaximin relieves global symptoms and bloating in people with IBS without constipation
Spiegel, B. M. R. (2011) · BMJ Evidence-Based Medicine · doi:10.1136/ebm1404
Irritable Bowel Syndrome : Studies of central pathophysiological mechanisms and effects of treatment
Lowén, M. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-122144
Statistical causality in participant-unblinded randomised community trials
Pierse, N. (2011) · Otago University Research Archive (University of Otago)
The hedonic placebo effect of traditional medicines
Sato, A., & Costa‐Font, J. (2012) · London School of Economics and Political Science Research Online (London School of Economics and Political Science)
ASk THE EXPERTS: Is There a Place for Placebo Analgesia in Everyday Clinical Practice?
Benedetti, F. (2011) · Pain Management · doi:10.2217/pmt.11.16
Psychiatric Applications of Placebos
Sohn, I., & Kim, I. (2014) · 대한정신약물학회지
Sivin, N. (2015) · Archimedes · doi:10.1007/978-3-319-20427-7_3
The Nature of Belief and its Normative Implications
Lee, C. (2016) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28253
This is to certify that the thesis/dissertation prepared
Hoblitzell, A., Mukhopadhyay, S., & Xia, Y. (2010)
Health care market in the Czech Republic in the information society
Luhan, J., & Novotná, V. (2014) · Business and management · doi:10.3846/bm.2014.077
Effekte, Bedingungen und Anwendung von Placebos
Werner, C., Hasler, S., Birkhäuer, J., & Gaab, J. (2016) · PSYCH up2date · doi:10.1055/s-0042-100680
Lessons from Placebo Arm Wrestle in Clinical Research
Nayak, D., & Chowdhury, N. (2014) · Psychiatric Annals · doi:10.3928/00485713-20140205-06 · Cited by 1
Functional bowel disorders and the role of mind-body therapies—The ‘Editors Choice’
Brindley, J. H., & Robinson, N. (2013) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2013.05.002
Han, B.-H. (2015) · Springer eBooks · doi:10.1007/978-981-287-748-2_2
Kremer, H.-J. (2016) · Journal of Pharmacy and Nutrition Sciences · doi:10.6000/1927-5951.2016.06.02.2
“Often cited is a 3-arm trial in irritable bowel disease [23].”
BackgroundChoi, S., & Lam, D. M. (2015) · Hong Kong Medical Journal · doi:10.12809/hkmj154738
The Humane Dimensions of Effective Communication
Hugman, B. (2012) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-4666-0309-7.ch003
Placebo and the Healing Process
SmithBattle, L., Pohlman, S., Palmer, J. L., Lorenz, R. A., & Cibulka, N. J. (2016) · Clinical Nursing Research · doi:10.1177/1054773816675562
“Interestingly, IBS symptoms declined among patients receiving this “open-label” placebo, and symptomatic relief was comparable with standard IBS medications (Kaptchuk et al., 2010).”
BackgroundThijssen, A. Y. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151119at
Placebo as Therapy for Low Back Pain?
Hoffmeister, E. (2017) · Lippincottʼs Bone and Joint Newsletter · doi:10.1097/01.bonej.0000512322.69148.55
La respuesta placebo en la depresión: Una revisión sistemática
Pérez-Vela, S., Facultad de Psicología, U. D. M., Navarro, J. F., & Facultad de Psicología, U. D. M. (2017) · Revista Iberoamericana de Psicología y Salud · doi:10.23923/j.rips.2017.08.006
Gavin-Breier, L. S. (2017) · Digital Commons - Olivet Distinctive Heritage, Scholarship, & Creativity (Olivet Nazarene University) · Cited by 1
Placebos and the Materiality of Belief
Jaarsma, A. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-57981-8_4
Die Beeinflussung des instrumentellen Lernens durch Placebo- und Noceboeffekte
Gunkel, L. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6431
Nutritional Approaches for Functional Bowel Disorders in an Integrative Medicine Clinic
Wagner, L. (2017) · KU ScholarWorks (The University of Kansas)
A placebo alkalmazásának etikai vonatkozásai
Bodnár, V., & Bárdos, G. (2017) · Magyar Pszichológiai Szemle · doi:10.1556/0016.2017.72.4.5
Hesselink, J. M. K., & Kopsky, D. J. (2018) · Journal of Pain & Relief · doi:10.4172/2167-0846.1000313
“The research group Kaptchuk demonstrated that it is possible to induce clinically meaningful placebo effects in disorders such as depression and irritable bowel syndrome by prescribing pure placebos explicitly without deceiving patients [5,6].”
BackgroundHarnessing placebo effects by targeting expectancies
Peerdeman, K. J. (2018) · Leiden Repository (Leiden University)
Traitement du syndrome du côlon irritable : l’impact de la microkinésithérapie
Grosjean, D., Bénini, P., & Carayon, P. (2018) · HEGEL - HEpato-GastroEntérologie Libérale · doi:10.3917/heg.082.0133
Placebo, Nocebo and no treatment
Grisold, W., & Grisold, S. (2018) · Revista de Fomento Social · doi:10.31190/rmn.2018.19.4.4.15
Placebo und Psychoanalyse – eine schwierige Beziehung
Schönbächler, G. (2018) · Vandenhoeck & Ruprecht eBooks · doi:10.13109/9783666402951.77
Placebo: A clinical, biological and ethical enigma
Greener, M. (2018) · Independent Nurse · doi:10.12968/indn.2018.12.28
Ballou, S. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.01.003
Implications of Placebos and Nocebos in Clinical Practice
Mitsikostas, D. D. (2019) · Headache · doi:10.1007/978-3-030-02976-0_11
Disorders of consciousness, memory, and will
Glannon, W. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198758853.003.0003
Euthanasia and assisted suicide for psychiatric disorders
Glannon, W. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198758853.003.0008
Glannon, W. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198758853.003.0002
Neuromodulation: Control, identity, and justice
Glannon, W. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198758853.003.0006
Placebos and Nocebos in Migraine: Children and Adolescents
Faria, V., & Borsook, D. (2019) · Headache · doi:10.1007/978-3-030-02976-0_8
Epilogue: Psychiatry, neuroscience, philosophy
Glannon, W. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198758853.003.0010
Sobrino-Cossio, S. R., & Teramoto-Matsubara, O. (2019) · NeuroGastroLATAM Reviews · doi:10.24875/ngl.18000014 · Cited by 1
A systematic review of non-invasive manual therapies in the management of irritable bowel syndrome
Badenhorst, N. (2019) · DUT Open Scholar (Durban University of Technology) · doi:10.51415/10321/3244
Psychosomatic Medicine and Consultation-Liaison Psychiatry in the United States
Leigh, H. (2019) · Springer eBooks · doi:10.1007/978-3-030-12584-4_23 · Cited by 1
Homéopathie et régimes d’exclusion : l’effet placebo en question !
Bertin, É. (2019) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2019.07.003
Rossow, L. M., Moon, J. M., Hiebert, L., Espitia, C., & Fahs, C. A. (2019) · Journal of Trainology · doi:10.17338/trainology.8.2_27
Placeboeffekte und ihre Implikationen in der Medizin
Bingel, U. (2020) · Schmerzmedizin · doi:10.1007/s00940-020-0593-8
Offen, unrein, methodisch: Diese Placebotypen sollten Sie kennen
Borchers, M. (2020) · HNO Nachrichten · doi:10.1007/s00060-020-7013-5
Are They Real? Examining the Regulatory Effects of Non-Deceptive Placebos on Emotional Distress
Guevarra, D. A. (2019) · Deep Blue (University of Michigan)
OBSOLETE: Visceral Pain: From Bench to Bedside
Elsenbruch, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.00019-5
Letter: placebo run‐in for IBS clinical trials ‐ is it useful? Authors' reply
Hamatani, T., Fukudo, S., Nakada, Y., Inada, H., Kazumori, K., & Miwa, H. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16047
Nursing Knowledge and the Placebo Effect
Chiffi, D. (2020) · Studies in applied philosophy, epistemology and rational ethics · doi:10.1007/978-3-030-59094-9_8
The Epistemology of Placebo Effect
Chiffi, D. (2020) · Studies in applied philosophy, epistemology and rational ethics · doi:10.1007/978-3-030-59094-9_7
Szalai-Szolcsányi, J. (2020) · Porta Lingua · doi:10.48040/pl.2020.38
Placebo-Effekte bei chronischen Schmerzen: Forschungsstand und klinische Anwendung
Müller, M., & Bräscher, A. (2021) · Physikalische Medizin Rehabilitationsmedizin Kurortmedizin · doi:10.1055/a-1186-6908
Schienle, A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.02.035
Psychological/Behavioral Therapies
Doleys, D. M., & Doleys, N. D. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780197544631.003.0022
Effect of Non-Deceptive Placebo on Weight Loss: A Preliminary StudyPreprint
Braswell, A. C., Ebeling, M., Wood, A. S., White, T. R., Lausen, M. A., Isaac, S., & Boggiano, M. M. (2021) · Research Square · doi:10.21203/rs.3.rs-410966/v1
“Finally, while speci c mechanisms have been theorized to explain the effectiveness of OLPs [5], to our knowledge, participants have not previously been asked to opine on the in uence of each of these mechanisms and other factors on their improved outcomes.”
BackgroundInfluentialRecent Researches in Sports Science
Dancs, H., Mike, H., Alfonso, P.-T., Gaillard, J., Kar, B. D. P., Intézet, S., Szombathely, S. I. –., Egyetem, N.-M., & Művészeti, N. É. S. K. (2020)
Efeito do placebo aberto no desempenho esportivo de ciclistas mulheres
Saito, T. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2020.tde-22072021-170537
Preferences, Equipoise, and Blinding
Powell, L. H., Kaufmann, P. G., & Freedland, K. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-39330-4_10
de Augustinis, J. (2020) · Research portal (Tilburg University)
A statistical approach to improving accuracy in classifier ensembles
Holness, G. F. (2008) · ScholarWorks@UMassAmherst (University of Massachusetts Amherst)
Examinando um poderoso efeito de cura através de uma lente cultural, e encontrando significado
Moerman, D. E., & Cervo, M. (2022) · Equatorial – Revista do Programa de Pós-Graduação em Antropologia Social · doi:10.21680/2446-5674.2022v9n16id25760
Chang, M. (2014) · Chapman & Hall/CRC eBooks · doi:10.1201/b17167-9
Blasini, M., Corsi, N., & Colloca, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-95369-4_17 · Cited by 1
Breath Testing and Small Bowel Organisms in Clinical Practice
Baker, S. S., & Baker, R. D. (2022) · JPGN Reports · doi:10.1097/pg9.0000000000000186
“Is it possibly explained by a placebo effect (10)?”
The Neural Correlates of Expectations Effects
Wicht, C. A. (2022) · doi:10.51363/unifr.sth.2022.003
Friehs, T., & Κube, T. (2022) · Psychotherapeut · doi:10.1007/s00278-022-00591-0
“DieWirksamkeit der Behandlung kann über eine positive therapeutische Information,durch ein klares Behandlungsrational sowie Patientenberichte und weitere Medienempfehlungen geschehen (Bishop et al. 2017; Kaptchuk et al. 2010).”
BackgroundElliott, D. L. (2019) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/69943
Ernst, E. K., & Smith, K. (2018) · Springer eBooks · doi:10.1007/978-3-319-69941-7_6
Glannon, W. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198758853.003.0005
Badcott, D. (2015) · Springer eBooks · doi:10.1007/978-3-319-05544-2_339-1
Sidani, S., & Braden, C. J. (2021) · Wiley eBooks · doi:10.1002/9781119610113.ch15
Biegler, P. (2015) · Springer eBooks · doi:10.1007/978-3-319-05544-2_73-1
Louhiala, P. (2020) · The International Library of Bioethics · doi:10.1007/978-3-030-27329-3_1
Biegler, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-09483-0_73
Metadata
- Authors
- Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- National Institutes of Health (US)
- University of Hull (GB)
- Corresponding author
- Kaptchuk, Ted J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-22
- Volume
- 5
- Issue
- 12
- Pages
- e15591
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3008733
- OpenAlex
- W2105330971
- Semantic Scholar
- 3d8aac4fba0e556c2d0898ad83cd3df11576e90c
- Cited by
- 900
- References
- 43
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 48 · 2023: 56 · 2022: 55 · 2021: 67 · 2020: 72 · 2019: 55 · 2018: 97 · 2017: 48 · 2016: 55 · 2015: 55 · 2014: 65 · 2013: 48 · 2012: 58
- FWCI
- 29.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Health and Human Services
- Bernard Osher Foundation
- National Institutes of Health (5r01at000402-04)
- Japan Society for the Promotion of Science (13J11021)
- National Center for Complementary and Alternative Medicine
- National Center for Complementary and Integrative Health (R01AT004662, K24AT004095, R01 AT00402-01)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Complementary and alternative medicine › Acupuncture Treatment Research Studies
- Keywords
- irritable bowel syndrome, placebo effect, open-label placebo, symptom severity, quality of life, patient-provider interaction, informed consent
- MeSH terms
- Adult, Female, Humans, Deception, Male, Middle Aged, Placebos, Time Factors, Treatment Outcome, Patient Satisfaction, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

